<p>(<b>A</b>) Neutralization curves of inferred intermediate antibodies on wild-type JR-FL virus (<b>B</b>) JR-FL N301A mutant virus, and (<b>C</b>) JR-FL N332A mutant virus. (<b>D</b>) Neutralization curves of 3H+3L and (<b>E</b>) PGT121 on wild-type JR-FL virus compared to single and double glycan mutant viruses. (<b>F</b>) Neutralization curves of PGT121 on wild-type 92BR020 virus compared to single and double glycan mutant viruses.</p
The V3 region of the human immunodeficiency virus type 1 envelope protein gp120 constitutes a potent...
AbstractThe N-glycan g15 within the HIV-1 gp120 V3 loop efficiently blocks antibodies to facilitate ...
Broadly neutralizing antibodies (bnAbs) against human immunodeficiency virus (HIV)-1 are rare in nat...
<p>Sera with V1V2 and V3 glycan-dependent HIV-1 NAbs are detected by neutralization assays with the ...
<p>Each point represents the geometric mean of viruses tested for neutralization sensitivity using e...
<p>To gauge if nAb responses continued to exert pressure, specifically against escape glycans, on th...
<p>The JR2 F673L mutant was subjected to various glycosylation conditions and the corresponding viru...
<p>(<b>A</b>) Diagram of the MPER and surrounding domains of HIV-1 gp41 with residues found to be im...
Worldwide, over 37 million people are currently infected with rapidly mutating human immunodeficienc...
<div><p>Understanding the molecular determinants of sensitivity and resistance to neutralizing antib...
AbstractA conserved N-glycan present within the V3 loop of gp120 modulates the sensitivity to neutra...
<p>(A) The epitopes on the HIV-1 Env trimer recognized by the monoclonal antibodies used in this stu...
Neutralization-resistant simian-human immunodeficiency virus AD8 (SHIVAD8) variants that emerged in ...
Broadly neutralizing antibodies (bNAbs) against HIV-1 envelope (Env) inform vaccine design and are p...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
The V3 region of the human immunodeficiency virus type 1 envelope protein gp120 constitutes a potent...
AbstractThe N-glycan g15 within the HIV-1 gp120 V3 loop efficiently blocks antibodies to facilitate ...
Broadly neutralizing antibodies (bnAbs) against human immunodeficiency virus (HIV)-1 are rare in nat...
<p>Sera with V1V2 and V3 glycan-dependent HIV-1 NAbs are detected by neutralization assays with the ...
<p>Each point represents the geometric mean of viruses tested for neutralization sensitivity using e...
<p>To gauge if nAb responses continued to exert pressure, specifically against escape glycans, on th...
<p>The JR2 F673L mutant was subjected to various glycosylation conditions and the corresponding viru...
<p>(<b>A</b>) Diagram of the MPER and surrounding domains of HIV-1 gp41 with residues found to be im...
Worldwide, over 37 million people are currently infected with rapidly mutating human immunodeficienc...
<div><p>Understanding the molecular determinants of sensitivity and resistance to neutralizing antib...
AbstractA conserved N-glycan present within the V3 loop of gp120 modulates the sensitivity to neutra...
<p>(A) The epitopes on the HIV-1 Env trimer recognized by the monoclonal antibodies used in this stu...
Neutralization-resistant simian-human immunodeficiency virus AD8 (SHIVAD8) variants that emerged in ...
Broadly neutralizing antibodies (bNAbs) against HIV-1 envelope (Env) inform vaccine design and are p...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
The V3 region of the human immunodeficiency virus type 1 envelope protein gp120 constitutes a potent...
AbstractThe N-glycan g15 within the HIV-1 gp120 V3 loop efficiently blocks antibodies to facilitate ...
Broadly neutralizing antibodies (bnAbs) against human immunodeficiency virus (HIV)-1 are rare in nat...